NCT06615115

Brief Summary

Parkinson's disease is the most common progressive neurodegenerative movement disorder. Common movement impairments in Parkinson's include balance and walking difficulties. These impairments lead to falls, increased levels of functional dependency, and a decrease in quality of life. Exercise in Parkinson's patients improves their functional symptoms in daily life, enhancing both motor and non-motor skills, and consequently increases their quality of life. Recently, various additional methods have been developed to increase the effectiveness of exercise in Parkinson's rehabilitation and to contribute to motor skills. Focus of attention instructions are fundamental concepts in motor function learning. External focus of attention has been shown to facilitate motor function development, reduce postural instability, and improve dual-task walking by being easier to remember. In Parkinson's patients who experience freezing phenomena, internal focus of attention instructions enhance walking stability and movement control, thereby reducing the risk of falls. However, there are no studies on the combined focus of attention instructions in Parkinson's patients. This study is designed as a randomized controlled, single-blind, prospective trial to examine the effects of a combination of internal and external focus of attention instructions on walking, balance parameters, quality of life, and patient satisfaction levels, taking into account the presence of freezing phenomena in Parkinson's patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P50-P75 for not_applicable parkinson-disease

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 24, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 26, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

January 30, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

February 11, 2025

Status Verified

February 1, 2025

Enrollment Period

4 months

First QC Date

September 24, 2024

Last Update Submit

February 10, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Berg Balance Scale

    This is a 14-item scale that measures the ability to maintain balance during dynamic tasks. It is rated on a scale of 0 to 4 points, with a maximum total score of 56. As the total score decreases, the risk of falling increases. 0 to 20 points: Indicates that the individual is dependent on a wheelchair and has a 100% risk of falling. 21 to 40 points: Suggests that the individual has a moderate risk of falling and may be able to walk with assistance. 41 to 56 points: Indicates that the individual can ambulate independently with a low risk of falling.

    baseline, six weeks after the baseline

  • Time Up and Go Dual Task

    The test assesses balance, walking, and functionality during activities. The TUG-Dual Task evaluates walking abilities and attention management by asking participants to solve a simple math problem or perform another cognitive task while walking. Patients will be assessed for functionality, walking speeds, and balance evaluations. If the duration lasts more than 12 seconds, there is a risk of falling.

    baseline, six weeks after the baseline

Secondary Outcomes (1)

  • The Parkinson's Disease Questionnaire-39 (PDQ-39)

    baseline, six weeks after the baseline

Other Outcomes (1)

  • Likert Scale Questionnaire

    baseline, six weeks after the baseline

Study Arms (3)

Group1: Exercises with External Attention Focus Instructions

EXPERIMENTAL

Throughout the descriped exercise program, the physiotherapist will guide the participants using only external focus of attention instructions. Example: Go over the red block. (10 rounds )

Other: Exercise

Group 2: Exercises with Combined Attention Focus Instructions

EXPERIMENTAL

The exercise program given to the External Focus of Attention group will also be administered to this group. While guiding the exercises, the physiotherapist will use a combination of both external and internal focus of attention instructions to direct the participants. Example: Pass over the red block by pulling your knees up as high as you can.

Other: Exercise

Grup 3: Exercises with no instructions (Control Group)

EXPERIMENTAL

The same exercise program given to the other groups will also be administered to this group but no instruction will be given to this group. Example: Take 10 turn around the track, passing over the blocks

Other: Exercise

Interventions

All participants will perform a total body stretching exercise for 10 minutes, followed by 10 minutes of obstacle course navigation, 10 minutes of balance training (including tandem walking, balance board exercises, single-leg balance, and two-legged reaching exercises), and will conclude with 10 minutes of strength training exercises.

Group 2: Exercises with Combined Attention Focus InstructionsGroup1: Exercises with External Attention Focus InstructionsGrup 3: Exercises with no instructions (Control Group)

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hoehn and Yahr Stage II or III
  • Individuals between the ages of 50 and 70 who can walk independently but have balance disorders
  • Having a score between 21-56 on the Berg Balance Scale
  • Having a score between 24-30 on the Mini Mental State Test
  • Having agreed to participate in the study (Not having a freezing phenomenon)
  • Being in the Medication-on period

You may not qualify if:

  • Having malignancy and metabolic diseases
  • Having had Cerebrovascular Accident before
  • Other neurological disease history
  • Presence of cognitive problems
  • Presence of visual or hearing disorders
  • Presence of deep brain pacemaker
  • Presence of freezing phenomenon (persons with Freezing of Gait Questionnaire FOG-Q above zero)
  • Presence of dyskinesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atafiz Tıp Merkezi

Istanbul, 34636, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Parkinson DiseaseGait Disorders, Neurologic

Interventions

Exercise

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Leyla Koçak, PT

    Bahcesehir University, Faculty of Health Sciences, Department of Physiotherapy

    PRINCIPAL INVESTIGATOR
  • Pelin Pişirici, PT, PhD

    Bahcesehir University, Faculty of Health Sciences

    STUDY DIRECTOR

Central Study Contacts

Pelin Pişirici, PT, PhD

CONTACT

Selen Gür Özmen, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The participant will do the evaluations but no info will be given about the randomization adn groups.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants who meet the inclusion criteria will be randomized into external focus of attention, combined focus of attention, and control groups. The same exercise program will be administered to all three groups by the same physiotherapist. The exercise program will last for 6 weeks, with sessions held three times a week. Although the exercises will be the same, the instructions given to the patients will vary by group. Assessments will be repeated at the beginning of treatment and at the end of the 6th week by a blinded evaluator.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, PT, PhD

Study Record Dates

First Submitted

September 24, 2024

First Posted

September 26, 2024

Study Start

January 30, 2025

Primary Completion

May 30, 2025

Study Completion

December 30, 2025

Last Updated

February 11, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations